TY - JOUR
T1 - The VENERE study: EffectiVenEss of a rehabilitation treatment with Nordic walking in obEse or oveRweight diabetic patiEnts with cardiovascular disease
AU - Torri, Anna
AU - Volpato, Eleonora
AU - Merati, Giampiero
AU - Milani, Martina
AU - Toccafondi, Anastasia
AU - Formenti, Damiano
AU - La Rosa, Francesca
AU - Agostini, Simone
AU - Agliardi, Cristina
AU - Oreni, Letizia
AU - Sacco, Alice
AU - Rescaldani, Marta
AU - Lucreziotti, Stefano
AU - Giglio, Ada
AU - Ferrante, Giulia
AU - Ferrante, Maria Giulia
AU - Barbaro, Maristella
AU - Montalto, Claudio
AU - Buratti, Stefano
AU - Morici, Nuccia
PY - 2024
Y1 - 2024
N2 - Background: Nordic walking (NW) has several potential benefits for individuals with cardiovascular disease (CV), type 2 diabetes, and obesity/overweight. It improves cardiovascular health, including exercise capacity and blood pressure control. It enhances glycemic control and insulin sensitivity in diabetes. It aids in weight management and body composition improvement. NW offers additional advantages such as improved muscular strength, joint mobility, physical activity levels, and psychological well-being.
Methods: This open-label study with three arms will aim to evaluate the efficacy, safety, and adherence to exercise prescription in obese/overweight diabetic patients with CV complications. The primary objective will be to assess the CV performance of participants after a 6- and 12-month follow-up period, following a 3-month NW intervention, compared with standard rehabilitation (SR) and cardiological counseling (control group, CG) training lasting 3 months.
Results: The results of the study will provide valuable insights into the comparative effectiveness of a NW intervention versus SR and CG training in improving cardiovascular performance in obese/overweight diabetic patients with CV complications. Additionally, safety and adherence data will help inform the feasibility and sustainability of the exercise prescription over an extended period.
Conclusions: These findings may have implications for the development of tailored exercise programs for this specific patient population, with the aim of optimizing cardiovascular health outcomes.
AB - Background: Nordic walking (NW) has several potential benefits for individuals with cardiovascular disease (CV), type 2 diabetes, and obesity/overweight. It improves cardiovascular health, including exercise capacity and blood pressure control. It enhances glycemic control and insulin sensitivity in diabetes. It aids in weight management and body composition improvement. NW offers additional advantages such as improved muscular strength, joint mobility, physical activity levels, and psychological well-being.
Methods: This open-label study with three arms will aim to evaluate the efficacy, safety, and adherence to exercise prescription in obese/overweight diabetic patients with CV complications. The primary objective will be to assess the CV performance of participants after a 6- and 12-month follow-up period, following a 3-month NW intervention, compared with standard rehabilitation (SR) and cardiological counseling (control group, CG) training lasting 3 months.
Results: The results of the study will provide valuable insights into the comparative effectiveness of a NW intervention versus SR and CG training in improving cardiovascular performance in obese/overweight diabetic patients with CV complications. Additionally, safety and adherence data will help inform the feasibility and sustainability of the exercise prescription over an extended period.
Conclusions: These findings may have implications for the development of tailored exercise programs for this specific patient population, with the aim of optimizing cardiovascular health outcomes.
KW - Nordic walking (NW)
KW - Six Minute Walking Test (6MWT)
KW - adherence
KW - biomarker
KW - cardiovascular disease
KW - obesity
KW - overweight
KW - rehabilitation
KW - type 2 diabetes
KW - Nordic walking (NW)
KW - Six Minute Walking Test (6MWT)
KW - adherence
KW - biomarker
KW - cardiovascular disease
KW - obesity
KW - overweight
KW - rehabilitation
KW - type 2 diabetes
UR - http://hdl.handle.net/10807/266856
UR - https://www.sciencedirect.com/science/article/pii/s2589790x24000234
U2 - 10.1016/j.cjco.2024.01.002
DO - 10.1016/j.cjco.2024.01.002
M3 - Article
SN - 2589-790X
VL - 2024
SP - 1
EP - 32
JO - CJC Open
JF - CJC Open
ER -